MedTrace Logo

Baveno Classification Versus Polysomnography in Obstructive Sleep Apnea

NCT07594288 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 395

Last updated 2026-05-18

No results posted yet for this study

Summary

Obstructive sleep apnea is a common disorder associated with significant cardiovascular and metabolic risks. Polysomnography is considered the gold standard for diagnosis and severity assessment; however, it may not fully reflect symptom burden and comorbidity profiles. The Baveno classification has been proposed as a multidimensional clinical tool that integrates symptoms and comorbidities to guide treatment decisions.

This retrospective study aims to evaluate the agreement between the Baveno classification and polysomnography results in patients with obstructive sleep apnea. The study includes adult patients who underwent overnight polysomnography between January 2016 and June 2024. Clinical data, including symptom burden and comorbid conditions, were collected from medical records and used to classify patients according to the Baveno system.

The primary objective is to assess the concordance between the Baveno classification and polysomnography-based disease severity and treatment recommendations. Secondary analyses explore the distribution of disease severity across Baveno groups and the potential implications for clinical decision-making.

The findings of this study may provide insight into the clinical utility of the Baveno classification as a complementary tool to polysomnography in the management of obstructive sleep apnea.

Conditions

Sponsors & Collaborators

  • Hisar Intercontinental Hospital

    lead OTHER

Principal Investigators

  • Orhan Dalkılıç, MD · Department of Pulmonology, Hisar Intercontinental Hospital and Uskudar University School of Medicine, Istanbul, Turkiye

  • Nesrin Sarıman, MD, Prof. · Department of Pulmonology, Hisar Intercontinental Hospital , Istanbul, Turkiye

  • Bekir Sami Uyanık, MD, Prof. · Department of Clinical Biochemistry, Hisar Intercontinental Hospital, Istanbul, Turkiye

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2024-06-30
Completion
2024-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07594288 on ClinicalTrials.gov